The Effects of Individualized Oxygen Dynamic on Prognosis of Patients With High-risk Cardiac Surgery

Effects of Perioperative Goal-Directed Therapy Based on Individualized Oxygen Balance on Outcomes During High-risk Cardiac Surgery:A Single Center, Prospective,Randomized,Controlled,Double Blinded Study.

Anesthesia-related factors have been linked to poor perioperative outcomes. Our observational study suggested that the cumulative duration of a triple-low state [intraoperative low mean arterial pressure (MAP), low bispectral index (BIS), and low target effect-site concentration(Ce) ]was associated with poorer 30-day mortality.This randomized, prospective study based on individualized Oxygen dynamics is designed to confirm this association in high-risk patients cardiopulmonary bypass (CPB).

Study Overview

Study Type

Interventional

Enrollment (Actual)

286

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Anhui
      • Hefei, Anhui, China, 230022
        • The First Affiliated Hospital of Anhui Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Written informed consent;
  2. Selective cardiac surgery and general anesthesia patients;
  3. Age 18-90 yrs;
  4. Anesthesia Society of American (ASA) Scale II-IV
  5. European System for Cardiac Operative Risk Evaluation score equal to or greater than 6 or left ventricular ejection fraction lower than 50%

Exclusion Criteria:

  1. Preoperative cardiac ejection fraction<30 %;
  2. History of anesthesia awareness;
  3. History or anticipation of difficult intubation;
  4. Unanticipated intraoperative conditions, including haemorrhage, obstinate resuscitation failure,multiple cardiopulmonary bypass procedures, severe hypotension or hypoxemia;
  5. long-term preoperative use of anticonvulsant agents, opiates, benzodiazepines or cocaine.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Individualized Goal-Directed Therapy
The goal of intervention:mean artery pressure declined with less than 20% of baseline, BIS 45-60 before and after CPB; and BIS 40-45 during CPB, Brain oxygen saturation declined with less than 20% of baseline.
mean artery pressure declined with less than 20% of baseline
BIS 45-60 before and after CPB; and BIS 40-45 during CPB
Other Names:
  • BIS
Brain oxygen saturation declined with less than 20% of baseline
SHAM_COMPARATOR: Controlled
no intervention beside the same monitoring with MAP, BIS and brain oxygen saturation and receiving standard measures to achieve a heart rate (HR) in the range of 60-100 beats/min, central venous oxygen saturation (Svco2) higher than 70%, lactate level lower than 3 mmol/L, hematocrit value higher than 28%, and urinary output higher than 0.5 mL/kg/hr.
receiving standard measures to achieve a heart rate (HR) in the range of 60-100 beats/min, central venous oxygen saturation (Svco2) higher than 70%, lactate level lower than 3 mmol/L, hematocrit value higher than 28%, and urinary output higher than 0.5 mL/kg/hr.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Major postoperative complications(i.e., Rate of low cardiac output syndrome, stroke, myocardial ischemia, infection,reoperation, and need for dialysis)
Time Frame: 30-day after surgery
Number of Participants with major complications extracted after 30-day follow-up
30-day after surgery
30-day mortality
Time Frame: 30-day after surgery
Data for duration of postoperative 30-day all-cause mortality
30-day after surgery
The change of incidence of postoperative delirium
Time Frame: The 1,2,3 day after surgery
Through Confusion Assessment Method (CAM)to assess the incidence of the postoperative delirium
The 1,2,3 day after surgery
1,3,5-year mortality
Time Frame: 1,3,5-year after surgery
Data for duration of 1,3,5-year all-cause mortality is extracted after 1-year follow-up
1,3,5-year after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative hospital stay
Time Frame: 30-day after surgery
Data for duration of postoperative hospital stay is extracted after 30-day follow-up
30-day after surgery
The change of incidence of postoperative cognition dysfunction
Time Frame: 1 day before surgery, the 3,7 day after the surgery
The neuropsychological tests performed at the day before the surgery,the 3,7 day after the surgery respectively.
1 day before surgery, the 3,7 day after the surgery
The occurrence of cardiovascular events
Time Frame: 30-day after surgery
Data for duration of the occurrence of cardiovascular events is extracted 30-day follow-up
30-day after surgery
The incidence of any adverse events
Time Frame: 30-day after surgery
Including kidney or brain related adverse events 30-day after surgery
30-day after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 5, 2017

Primary Completion (ACTUAL)

June 30, 2018

Study Completion (ACTUAL)

July 30, 2018

Study Registration Dates

First Submitted

April 1, 2017

First Submitted That Met QC Criteria

April 5, 2017

First Posted (ACTUAL)

April 6, 2017

Study Record Updates

Last Update Posted (ACTUAL)

March 25, 2019

Last Update Submitted That Met QC Criteria

March 21, 2019

Last Verified

April 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FirstAnhuiM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Disease

Clinical Trials on mean artery pressure

3
Subscribe